BN Business News
Add your company to Business Communicator →

Business · 09/09/2026

FDA Announces Temporary Guidance for Compounding Parenteral Nutrition Drugs for Neonates

The FDA is releasing a new guidance document outlining its priorities for regulating the compounding of certain starter parenteral nutrition drugs for neonates, as a major supplier is set to exit the US market

Original source language: Federal Register — Health and Human ServicesOpen original release →

Explore insights